Literature DB >> 21420946

Vitreous and serum levels of transthyretin (TTR) in high myopia patients are correlated with ocular pathologies.

Jun Shao1, Yu Xin, Rongxiu Li, Ying Fan.   

Abstract

PURPOSE: To detect serum and vitreous transthyretin (TTR) in high myopia patients and to evaluate potential associations between TTR and clinical parameters and ocular pathologies, including different ocular pathologies. DESIGN AND METHODS: Serum samples from 16 high myopia patients and 4 controls were analyzed by LTQ-MASS. Serum samples from 116 high myopia patients and 86 healthy controls were tested by Western blots and ELISA. Eight healthy and 40 pathologic vitreous samples were analyzed by ELISA. And corresponding serum samples were also analyzed by ELISA.
RESULTS: Significant increased TTR serum levels were detected in high myopia patients compared to healthy controls. The high levels of serum TTR were associated with ocular pathologies, long axial length, and low visual acuity. TTR in high myopia patients with macular hole and macular detachment was upregulated in both vitreous and the corresponding serum samples. TTR levels in serum samples of high myopia patients with long axial lengths were higher than in the vitreous.
CONCLUSIONS: Serum TTR may be a biomarker for high myopia patients with ocular pathologies.
Copyright © 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420946     DOI: 10.1016/j.clinbiochem.2011.03.032

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Negative effects of transthyretin in high myopic vitreous on diabetic retinopathy.

Authors:  Jun Shao; Yong Yao
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

2.  Repression of retinal microvascular endothelial cells by transthyretin under simulated diabetic retinopathy conditions.

Authors:  Jun Shao; Yong Yao
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

3.  Transthyretin represses neovascularization in diabetic retinopathy.

Authors:  Jun Shao; Yong Yao
Journal:  Mol Vis       Date:  2016-10-12       Impact factor: 2.367

4.  Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy.

Authors:  Jun Shao; Yunbin Zhang; Guangming Fan; Yu Xin; Yong Yao
Journal:  BMC Med Genomics       Date:  2019-10-15       Impact factor: 3.063

5.  Transthyretin Upregulates Long Non-Coding RNA MEG3 by Affecting PABPC1 in Diabetic Retinopathy.

Authors:  Guangming Fan; Yu Gu; Jiaojiao Zhang; Yu Xin; Jun Shao; Francesca Giampieri; Maurizio Battino
Journal:  Int J Mol Sci       Date:  2019-12-13       Impact factor: 5.923

6.  iTRAQ Quantitative Proteomic Analysis of Vitreous from Patients with Retinal Detachment.

Authors:  Fátima Milhano Santos; Leonor Mesquita Gaspar; Sergio Ciordia; Ana Sílvia Rocha; João Paulo Castro E Sousa; Alberto Paradela; Luís António Passarinha; Cândida Teixeira Tomaz
Journal:  Int J Mol Sci       Date:  2018-04-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.